ARCUTIS BIOTHERAPEUTICS INC (ARQT) Institutional Ownership and Insiders Activity
ARCUTIS BIOTHERAPEUTICS INC (ARQT) is widely held by institutional investors, with 290 firms reporting positions valued at approximately $3.82B based on SEC Form 13F filings for the quarter ended September 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $506.69M in ARQT holdings in its latest filing.
Recent insider activity includes 23 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
290
Total Reported Value
$3.82B
Largest Holder
Blackrock, Inc.
Largest Position
$506.69M
Insider Transactions (90d)
23
Latest Filing Quarter
Q3 2026
New Institutional Positions
68
Funds Exiting Positions
48
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$506.69M
- Suvretta Capital Management, Llc$326.10M
- Frazier Life Sciences Management, L.P.$258.91M
- Rubric Capital Management Lp$216.88M
- State Street Corp$204.00M
Related ARQT Institutional Insights:
- ARQT 13F Institutional Holders
- ARQT Superinvestors
- ARQT Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ARQT Insider Trading & SEC Form 4 Activity
- ARQT Articles
- Top Institutional Investor Stock Rankings